MYC is one of the most frequently overexpressed oncogenes in human cancer and even modestly deregulated MYC can initiate ectopic proliferation in many post-mitotic cell types in vivo. Sensitization of cells to apoptosis limits MYC’s oncogenic potential. However, the mechanism through which MYC induces apoptosis is controversial: Some studies implicate p19ARF-mediated stabilization of p53, followed by induction of pro-apoptotic BH3 proteins NOXA and PUMA, while others argue for direct regulation of BH3 proteins, especially BIM. Here, we use a single experimental system to systematically evaluate the roles of p19ARF and BIM during MYC-induced apoptosis, in vitro, in vivo, and in combination with a widely used chemotherapeutic, Doxorubicin. We find a common specific requirement for BIM during MYC-induced apoptosis in multiple settings, which does not extend to the p53-responsive BH3 family member PUMA, and find no evidence of a role for p19ARF during MYC-induced apoptosis in the tissues examined.